Contrast Media Screening Questionnaire: Risk Factors, Templates & Requirements


Key Takeaways
- A contrast media screening questionnaire identifies patient risk factors before imaging procedures involving iodinated or gadolinium-based contrast agents.
- Critical screening areas include prior reactions, allergies, renal function, cardiovascular history, diabetes status, and current medications like metformin.
- Compliance with the ACR Manual on Contrast Media, CMS supervision rules, and HIPAA standards is mandatory for outpatient imaging facility workflows.
- Effective templates use structured intake questions, risk-stratification tiers, and clear escalation paths for technologists to flag high-risk cases quickly.
- At ContrastConnect, we back screening protocols with virtual contrast supervision, so facilities maintain CMS compliance and instant response readiness.
What Goes Into a Safe Contrast Screening Form?
A contrast media screening questionnaire is a structured pre-procedure form that documents allergy history, prior contrast reactions, renal function, current medications, and comorbid conditions to identify patients at risk of adverse reactions to iodinated or gadolinium-based contrast. Imaging facilities use the answers to decide on premedication, contrast type, dose, supervision level, and post-scan monitoring before any injection occurs.
Key risk factors include prior reactions, asthma and atopy, reduced eGFR, diabetes with metformin use, cardiac disease, and pregnancy. Requirements stem from the ACR Manual on Contrast Media, CMS direct supervision rules, HIPAA, and state licensing standards. Templates that pair structured intake questions with a clear risk-stratification tier and escalation path give technologists a defensible workflow for every scan.
ContrastConnect supports that workflow with on-demand virtual contrast supervision, ensuring a qualified radiologist is immediately available when escalated screening cases require it.
What Is a Contrast Media Screening Questionnaire?
A contrast media screening questionnaire is a standardized intake form completed before a patient receives intravenous contrast for CT, MRI, angiography, or interventional procedures.
It captures medical history, allergies, current medications, and physiological factors that influence the likelihood and severity of an adverse reaction. Both iodinated (CT) and gadolinium-based (MRI) agents carry distinct risk profiles, and the questionnaire serves as the first safety checkpoint in the imaging workflow.
The completed form supports several clinical decisions, including the need for premedication, the chosen contrast type and dose, the required level of supervision, and the post-scan monitoring window. It also creates the audit trail that imaging facilities rely on during CMS inspections, accreditation reviews, and any post-event clinical investigation.

Key Patient Risk Factors to Screen For
Reliable screening targets the conditions most associated with mild, moderate, and severe contrast reactions. The ACR Manual on Contrast Media organizes these risks into categories that every questionnaire should mirror.
Prior Contrast Reactions & Allergies
A documented prior reaction to the same class of contrast agent is the strongest predictor of a future event. Patients with asthma, multiple drug allergies, or atopic disease carry an elevated baseline risk.
Questionnaires should capture the reaction type (hives, bronchospasm, anaphylaxis), timing, severity, and any premedication used, including any subsequent imaging. Seafood or shellfish allergy alone is no longer considered a meaningful indicator of iodinated contrast risk, though many forms still note it for completeness.
Renal Function & Kidney Disease
Iodinated contrast can contribute to contrast-induced acute kidney injury in patients with reduced glomerular filtration rate. Gadolinium agents have been linked to nephrogenic systemic fibrosis when older Group I agents are administered to patients with advanced chronic kidney disease.
Screening should capture recent serum creatinine or eGFR, dialysis status, history of renal transplant or single kidney, and acute kidney injury within the past 30 days.
Cardiovascular, Metabolic & Endocrine Conditions
Cardiac dysfunction, uncontrolled hypertension, and unstable arrhythmias affect tolerance to volume loading and contrast-related hemodynamic shifts. Diabetes intersects with metformin use, which is typically held around iodinated contrast in patients with reduced renal function.
Hyperthyroidism, untreated pheochromocytoma, and sickle cell disease also influence iodinated contrast decisions, and questionnaires should include direct questions about each condition.
Medications, Pregnancy & Other Considerations
Beta-blockers can complicate the treatment of anaphylactic reactions by blunting the epinephrine response, so the questionnaire should list current cardiac medications.
Pregnancy and lactation status guide gadolinium decisions for female patients of reproductive age. Myasthenia gravis, prior radiation therapy, and history of paraproteinemia, such as multiple myeloma, round out the conditions a thorough form should include.
Regulatory & Clinical Requirements for Contrast Screening
Outpatient imaging facilities follow several overlapping standards when designing and executing contrast screening.
The ACR Manual on Contrast Media is the primary clinical reference for risk stratification, premedication protocols, and reaction management. CMS direct supervision rules require a qualified physician to be immediately available during contrast administration, with virtual supervision permitted in outpatient settings under CMS rules adopted for 2026. State licensing boards may set additional requirements for technologists, and Joint Commission accreditation reviewers expect clear documentation that screening occurred and that a supervising physician was reachable.
HIPAA and HITECH requirements apply to the screening data captured. Forms stored electronically should sit inside the facility's EHR or a HIPAA-compliant platform, with retention policies and role-based access controls. Paper forms still require secure storage and a defined destruction schedule. Consent language for contrast administration is often integrated into the same document, simplifying patient sign-off and reducing missed signatures on high-volume scan days.
Contrast Media Screening Questionnaire Templates
Effective templates share several structural features regardless of facility size. They balance clinical thoroughness with patient readability and integrate cleanly with technologists' workflows on the day of the scan.
Pre-Procedure Patient Intake Template
The intake portion captures patient demographics, the ordered exam and indication, prior imaging and contrast history, a full allergy list with reaction details, the current medication list including metformin and beta-blockers, pregnancy status for female patients of reproductive age, recent renal labs with date drawn, and comorbid conditions across cardiac, renal, endocrine, and hematologic categories.
A signature line for the patient and the reviewing staff member follows. Many facilities use a yes/no checklist format with space for free-text clarification on any positive responses, which speeds chart review without losing detail.
Risk Stratification & Escalation Template
The second template layer turns answers into a defined risk tier. Low-risk patients proceed under standard protocol. Moderate risk triggers documented physician review, often with premedication using corticosteroid and antihistamine regimens specified in the ACR Manual.
High-risk cases require pre-procedure consultation with the supervising radiologist and may involve a different contrast agent, reduced dose, alternative imaging, or postponement. Clear escalation paths protect technologists. The form should specify who to contact, expected response time, and how the contact and resulting clinical decision are documented in the medical record.

Quick Reference: Screening Categories & Priorities
Why Pair Screening With ContrastConnect Supervision?

A well-built contrast media screening questionnaire turns patient history into a defensible safety decision before injection. The three pillars are complete coverage of risk factors across allergy, renal, cardiac, and medication history; alignment with the ACR Manual on Contrast Media, CMS supervision rules, and HIPAA standards; and a template that escalates moderate- and high-risk cases directly to the supervising radiologist.
At ContrastConnect, we provide the on-demand radiologist supervision that escalated screening cases depend on, with CMS-compliant coverage delivered through a secure platform and audit-ready documentation for every encounter. Our team supports outpatient imaging networks across daytime, evening, weekend, and holiday hours. Start your coverage assessment with our team today.
Start Your Coverage Assessment →
Frequently Asked Questions (FAQs)
How often should imaging facilities update contrast screening questionnaires?
Most facilities review screening questionnaires at least annually, with immediate updates after major ACR Manual revisions or new FDA contrast warnings. The 2020 update on iodinated contrast and acute kidney injury, for example, prompted many facilities to revise eGFR thresholds.
Periodic review keeps premedication protocols, renal screening, and consent language aligned with current clinical guidance and accreditation expectations.
Can patients refuse to complete a contrast screening form?
Patients can decline portions of a screening questionnaire, though most facilities require enough information to administer contrast safely.
When critical risk data is missing, the supervising radiologist may recommend postponing the exam or selecting an alternative imaging approach. Documentation of the patient refusal and the resulting clinical decision is required for the medical record and any later audit.
What happens if a patient's renal lab values are outdated at the time of screening?
Many facilities require serum creatinine or eGFR results within 30 to 60 days before iodinated contrast administration, with shorter windows for higher-risk patients.
If labs fall outside that window, point-of-care testing or a same-day draw can resolve the gap. Without current values, the supervising radiologist makes a case-by-case decision.
Are screening requirements different for pediatric patients?
Pediatric screening includes weight-based dosing checks, parental or guardian consent, and assessment of conditions such as prematurity or congenital renal anomalies. Allergy history collection often involves parental recall rather than direct patient report.
The ACR Manual offers pediatric-specific guidance on contrast selection, dosing, and monitoring that pediatric screening forms should closely reflect in their structure.
How does ContrastConnect support contrast screening across multi-site imaging networks?
ContrastConnect provides virtual contrast supervision for outpatient imaging networks managing 20 to 200+ facilities. Our specialized radiologists at ContrastConnect deliver immediate, CMS-compliant coverage with audit-ready documentation, supporting more than 75,000 hours of contrast exam supervision monthly.
Partner facilities reduce cancellations, extend operating hours, and scale safely without adding onsite radiologists.
*Note: Information provided is for general guidance only and does not constitute medical, legal, or financial advice. Pricing estimates and regulatory requirements are current at the time of writing and subject to change. For personalized consultation on imaging center operations and virtual contrast supervision, contact ContrastConnect.
Trusted Nationwide








































.avif)











.avif)











.avif)




1,000,000
Contrast exams supervised annually
75,000+
Hours of supervision monthly
3,900+
Technologists certified
100s
Of imaging partners nationwide
130+
Contrast reactions treated monthly
100%
Requested hours covered